Clinical Trials Arena September 23, 2025
Experts view AI and blockchain technology to be as fundamental as the internet to the future framework of clinical trials.
Artificial intelligence (AI) is expected to not only supplement clinical trials, but redefine the sector, while the industry braces for a fundamental transformation amid growing demand for patient centricity and sustainability, say experts.
New technologies and strategies in clinical trials were the subject of a panel discussion at the 2025 Clinical Trial Supply West Coast 2025 (CTSWC25) conference on 9 September in Burlingame, California. Panellists asserted that rising reliance on AI will set the foundation for future trial strategy while the sector adapts to participant demand for greater centricity and sustainability in trial design.
Today's Sponsors
Today's Sponsor